ALT

Altimmune Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 6/10
  • Value↓ 0/10
Altimmune sales and earnings growth
ALT Growth
Good
  • Revenue Y/Y↑ 42.10%
  • EPS Y/Y↑ 26.98%
  • FCF Y/Y↑ 10.78%
Altimmune gross and profit margin trends
ALT Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -253002.80%
  • ROIC 5Y↓ -108.77%
Altimmune net debt vs free cash flow
ALT Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -32.7

Altimmune stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks